ClinicalTrials.gov
ClinicalTrials.gov Menu

Assessing the Role of Exercise Intensity in Slowing Disease Progression in Early Parkinson’s Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00385073
Recruitment Status : Unknown
Verified October 2006 by Austin Health.
Recruitment status was:  Recruiting
First Posted : October 6, 2006
Last Update Posted : October 6, 2006
Sponsor:
Information provided by:
Austin Health

Brief Summary:
Participants will complete a self-selected intensity of exercising over a 6 month period, with detailed clinical assessments at commencement and completion to determine the rate of progression of parkinsonism and gait abnormalities

Condition or disease
Parkinson's Disease

Detailed Description:
Participants will complete a self-selected intensity of exercising over a 6 month period - including jogging, swimming and circuit training, with detailed clinical assessments at commencement and completion (including UPDRS, gaitrite lab study) to determine the rate of progression of parkinsonism and gait abnormalities

Study Type : Observational
Enrollment : 30 participants
Observational Model: Defined Population
Observational Model: Natural History
Time Perspective: Longitudinal
Time Perspective: Prospective
Official Title: Assessing the Role of Exercise Intensity in Slowing Disease Progression in Early Parkinson’s Disease
Study Start Date : April 2005
Study Completion Date : December 2007

Resource links provided by the National Library of Medicine






Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Early Parkinson's Disease,
  • Able to provide informed consent,
  • able to complete exercise diaries for 6 months,
  • no medications or on levo-dopa

Exclusion Criteria:

  • Not on dopamine agonists,

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00385073


Contacts
Contact: mary m Galea, PhD 0061383444171 m.galea@unimelb.edu.au

Locations
Australia
Royal Talbot Rehabilitation Centre Recruiting
Melbourne, Australia
Principal Investigator: mary galea, PhD         
Sponsors and Collaborators
Austin Health
Investigators
Principal Investigator: mary m galea, PgD Austin Health

ClinicalTrials.gov Identifier: NCT00385073     History of Changes
Other Study ID Numbers: 126/05
First Posted: October 6, 2006    Key Record Dates
Last Update Posted: October 6, 2006
Last Verified: October 2006

Additional relevant MeSH terms:
Parkinson Disease
Disease Progression
Parkinsonian Disorders
Basal Ganglia Diseases
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Movement Disorders
Neurodegenerative Diseases
Disease Attributes
Pathologic Processes